Wei-Chih Su is a prominent inventor based in Tainan County, Taiwan. He has made significant contributions to the field of biotechnology, holding a total of 9 patents. His work focuses on enhancing biological processes and developing innovative solutions for health-related challenges.

Latest Patents

Among his latest patents is a method for enhancing PPARγ expression. This invention provides a method for administering an effective amount of PM-A0005 to a subject in need, which has been deposited under the Budapest Treaty in the China Center for Type Culture Collection (CCTCC), China, with Deposition No. M 207039. Another notable patent involves novel strains of lactic acid bacteria aimed at preventing necrotizing enterocolitis. This invention includes subsp. PM-A0087, deposited as NRRL accession number B-50523, PM-A0101, deposited as NRRL accession number B-50525, and PM-A0218, deposited as NRRL accession number B-50524.

Career Highlights

Wei-Chih Su has worked with several companies in the biotechnology sector, including Genmont Biotech Inc. and Promd Biotech Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in the industry.

Collaborations

Throughout his career, Wei-Chih Su has collaborated with notable colleagues, including Ching-Hsiang Hsu and Hsiao-Li Wu. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Wei-Chih Su's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor in the field. His innovative methods and dedication to enhancing health solutions continue to make a significant impact.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com